Aligos Therapeutics Sponsored Study Titled 'A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects' Posted To Clinical Trials Website